AtlasXomics Inc.
Biotechnology company · New Haven, Connecticut, United States
AtlasXomics Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2020. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.1 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $3.9 million sold in a notice filed in 2022.
AtlasXomics at a glance
What does AtlasXomics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3.1 million in total (2022 to 2024). NIH funding came from the National Human Genome Research Institute, National Cancer Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $3.9 million sold (2022).
Frequently asked questions about AtlasXomics
Where is AtlasXomics headquartered?
AtlasXomics Inc. is headquartered in New Haven, Connecticut, United States.
What does AtlasXomics do?
AtlasXomics Inc. is a biotechnology company.
When was AtlasXomics founded?
The earliest incorporation on record for AtlasXomics Inc. is in 2020, according to public company registers.
Similar companies
- Allyx Therapeutics, Inc.New Haven, Connecticut, United States
- Invivyd, Inc.New Haven, Connecticut, United States
- ReNetX Bio, Inc.New Haven, Connecticut, United States
- Vion Pharmaceuticals IncNew Haven, Connecticut, United States
- ProteoWise Inc.New Haven, Connecticut, United States
- Oui Therapeutics IncNew Haven, Connecticut, United States
- Modifi Biosciences, Inc.New Haven, Connecticut, United States
- Cybrexa, Inc.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences